Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 10-12 February 2026
CVMP opinions on veterinary medicinal productsThe Committee adopted a positive opinion for a marketing authorisation for Emepax (maropitant), indicated for the …
